4-(4-溴苯基)-1,2,3-噻二唑； 4-(4-溴苯基)-1,2,3-噻二唑 | 40753-13-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(4-溴苯基)-1,2,3-噻二唑； 4-(4-溴苯基)-1,2,3-噻二唑
• 中文别名: 4-(4-溴苯基)-1,2,3-噻二唑；4-(4-溴苯基)1,2,3-噻二唑；4-(4-溴苯基)-1,2,3-噻二唑；4-(4-溴苯基)-1,2,3-噻二唑
• 英文名称: 4-(4-bromophenyl)-1,2,3-thiadiazole
• 英文别名: 4-(4-bromophenyl)thiadiazole
• CAS: 40753-13-7
• 化学式: C₈H₅BrN₂S
• 分子量: 241.111
• InChiKey: HGWOTVRPRHVJQK-UHFFFAOYSA-N

物化性质

• 熔点：
  154 °C
• 沸点：
  341.5±34.0 °C(Predicted)
• 密度：
  1.642±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  54
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2934999090
• 储存条件：
  储存条件：室温、密封、干燥

SDS

Name:	4-(4-Bromophenyl)-1 2 3-thiadiazole 97% Material Safety Data Sheet
Synonym:
CAS:	40753-13-7

Section 1 - Chemical Product MSDS Name:4-(4-Bromophenyl)-1 2 3-thiadiazole 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
40753-13-7	4-(4-Bromophenyl)-1,2,3-thiadiazole	97%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 40753-13-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H5BrN2S
Molecular Weight: 241.11

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide, hydrogen bromide, bromine.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 40753-13-7: XI3677500 LD50/LC50:
Not available.
Carcinogenicity:
4-(4-Bromophenyl)-1,2,3-thiadiazole - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 40753-13-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 40753-13-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 40753-13-7 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(4-溴苯基)-1,2,3-噻二唑； 4-(4-溴苯基)-1,2,3-噻二唑 在 甲醇 、 sodium 作用下， 反应 1.0h， 生成
  参考文献：
  名称：

  New method for the preparation of N,N-dimethyl-(thioacetamides) from 4-substituted 1,2,3-thiadiazoles

  摘要：

  DOI：

  10.1134/s1070428007120226
• 作为产物：
  描述：

  2'-氯-4-溴苯乙酮 在 potassium sulfide 、 potassium carbonate 作用下， 以 乙醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 0.5h， 生成 4-(4-溴苯基)-1,2,3-噻二唑； 4-(4-溴苯基)-1,2,3-噻二唑
  参考文献：
  名称：

  级联三硫自由基（S 3 •–）加成/电子脱甲苯磺酸合成1,2,3-噻二唑和异噻唑

  摘要：

  已经开发了三硫自由基阴离子（S 3 •–）与原位形成的偶氮烯烃和α，β-过饱和的N-磺酰亚胺类化合物介导的反应，用于构建1,2,3-噻二唑和异噻唑。S 3 •–是由DMF中的硫化钾原位生成的。这两种方法提供了一种新的，安全的和简单的方法来以高收率构建4-取代的1,2,3-噻二唑，5-取代的1,2,3-噻二唑和异噻唑。反应包括在温和条件下通过S 3 •加成形成新的C–S和N–S键和电子脱甲苯基化反应。

  DOI：

  10.1021/acs.joc.8b01450

文献信息

• Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them
  申请人：——

  公开号：US20040072871A1

  公开（公告）日：2004-04-15

  A compound of formula (I) selected from: 1 wherein: X represents oxygen or sulphur, Y represents oxygen, —NH— or —N(C 1 -C 6 )alkyl-, R a represents hydrogen, halogen, (C 1 -C 3 )alkyl, hydroxyl or (C 1 -C 3 )alkoxy, R b represents hydrogen, halogen or (C 1 -C 3 )alkyl, A represents phenyl, pyridyl, (C 5 -C 6 )cycloalkyl or (C 5 -C 6 )cycloalkenyl, R 1 and R 2 each represent a group selected from hydrogen, halogen, cyano, nitro, haloalkyl, haloalkoxy, alkyl, alkenyl, alkynyl, —OR 4 , —NR 4 R 5 , —S(O) n R 4 , —C(O)R 4 , —CO 2 R 4 , —O—C(O)R 4 , —C(O)NR 4 R 5 , —NR 5 —C(O)R 4 , —NR 5 —SO 2 R 4 , -T-CN, -T-OR 4 , -T-OCF 3 , -T- NR 4 R 5 , -T-S(O) n R 4 , -T-C(O)R 4 , -T-CO 2 R 4 , -T-O—C(O)R 4 , -T-C(O)NR 4 R 5 , -T-NR 4 —C(O)R 5 , -T-NR 4 —SO 2 R 5 , —R 6 and -T-R 6 in which n, T, R 4 , R 5 and R 6 are as defined in the description, R 3 represents an —R 7 or —U—R 11 group in which R 7 represents hydrogen, alkyl, aryl, cycloalkyl or heterocycle, U represents a linear or branched alkylene chain and R 11 is defined in the description, their optical isomers or their addition salts with a pharmaceutically acceptable acid or base, and their use as inhibitor of metalloproteinase and more specifically of metalloproteinase-12.

  公式（I）所选的化合物如下： 其中： X代表氧或硫， Y代表氧，-NH-或-N（C1-C6）烷基-， Ra代表氢，卤素，（C1-C3）烷基，羟基或（C1-C3）甲氧基， Rb代表氢，卤素或（C1-C3）烷基， A代表苯基，吡啶基，（C5-C6）环烷基或（C5-C6）环烯基， R1和R2分别代表从氢，卤素，氰基，硝基，卤代烷基，卤代甲氧基，烷基，烯基，炔基，-OR4，-NR4R5，-S（O）nR4，-C（O）R4，-CO2R4，-O—C（O）R4，-C（O）NR4R5，-NR5—C（O）R4，-NR5—SO2R4，-T-CN，-T-OR4，-T-OCF3，-T-NR4R5，-T-S（O）nR4，-T-C（O）R4，-T-CO2R4，-T-O—C（O）R4，-T-C（O）NR4R5，-T-NR4—C（O）R5，-T-NR4—SO2R5，-R6和-T-R6中选择的基团，其中n，T，R4，R5和R6如描述中所定义， R3代表-R7或-U-R11基团，其中R7代表氢，烷基，芳基，环烷基或杂环烷基，U代表线性或支链烷基链，R11如描述中所定义， 它们的光学异构体或它们与药学上可接受的酸或碱形成的加合盐，以及它们作为金属蛋白酶抑制剂，更具体地是金属蛋白酶-12的抑制剂的用途。
• Synthesis, characterization, antiamoebic activity and cytotoxicity of novel 2-(quinolin-8-yloxy) acetohydrazones and their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives)
  作者：Faisal Hayat、Attar Salahuddin、Jamil Zargan、Amir Azam

  DOI：10.1016/j.ejmech.2010.09.066

  日期：2010.12

  1,2,3-selenadiazole derivatives were synthesized by the cyclization of novel 2-(quinolin-8-yloxy) acetohydrazones. In vitro antiamoebic activity was performed against HM1: IMSS strain of Entamoeba histolytica. The results showed that all the 2-(quinolin-8-yloxy) acetohydrazones were more active than their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives). SAR showed that the

  通过新型2-（喹啉-8-酰氧基）乙酰的环化反应，合成了一系列1,2,3-噻二唑和1,2,3-硒代二唑衍生物。体外对溶组织性变形杆菌的HM1：IMSS菌株进行了抗厌氧活性。结果表明，所有的2-（喹啉-8-酰氧基）乙酰hydr均比其环化产物（1,2,3-噻二唑和1,2,3-硒代二唑衍生物）更具活性。SAR显示，具有喹啉环和键并带有游离N–H基团的化合物具有较高的抗氧活性。这些化合物对人乳腺癌MCF-7细胞系的细胞毒性研究表明，所有化合物在1.56–50μM的浓度范围内均无毒。
• 一种铜催化1,2,3-硫二唑化合物与胺合成硫代酰胺化合物的方法
  申请人：华南理工大学

  公开号：CN112778067B

  公开（公告）日：2022-05-24

  本发明属于有机化学的技术领域，公开了一种铜催化1,2,3‑硫二唑化合物与胺合成硫代酰胺化合物的方法。方法为在保护性氛围下，以有机溶剂为反应介质，将1,2,3‑硫二唑化合物与胺类化合物在铜盐催化剂或铜催化剂和膦配体的作用下反应，后续处理，获得硫代酰胺化合物。本发明的方法以铜盐为催化剂，并采用膦配体，产率较高、底物适用性广。此外，该反应以1,2,3‑硫二唑化合物和胺类化合物为原料，具有原料廉价易制备、操作简便、原子经济性高的优点。
• Synthesis and structure–activity relationships of novel lincomycin derivatives part 3: discovery of the 4-(pyrimidin-5-yl)phenyl group in synthesis of 7(S)-thiolincomycin analogs
  作者：Yoshinari Wakiyama、Ko Kumura、Eijiro Umemura、Satomi Masaki、Kazutaka Ueda、Yasuo Sato、Takashi Watanabe、Yoko Hirai、Keiichi Ajito

  DOI：10.1038/ja.2016.114

  日期：2017.1

  these novel lincomycin derivatives, we found that (a) the location of basicity in the C-7 side chain was an important factor to enhance antibacterial activities, and (b) compounds 22, 36, 42, 43 and 44 had potent antibacterial activities against a variety of Streptococcus pneumoniae with erm gene, which cause severe respiratory infections, even compared with our C-7-modified lincomycin analogs (1-4)

  通过7（S）-7-脱氧-7-硫代林可霉素（5）与Pd催化的交叉偶联反应合成了新的林可霉素衍生物，其通过硫原子在C-7位置具有一个芳基苯基或一个杂芳基苯基。芳基卤化物。该反应是合成多种7（S）-7-脱氧-7-硫代林可霉素衍生物的最有用的方法。在对这些新型林可霉素衍生物的构效关系进行分析的基础上，我们发现（a）碱在C-7侧链中的位置是增强抗菌活性的重要因素，并且（b）化合物22、36 ，42、43和44与先前报道的C-7修饰的林可霉素类似物（1-4）相比，对具有erm基因的多种肺炎链球菌均具有有效的抗菌活性，这些细菌可引起严重的呼吸道感染。此外，
• Synthesis and SARs of novel lincomycin derivatives Part 5: optimization of lincomycin analogs exhibiting potent antibacterial activities by chemical modification at the 6- and 7-positions
  作者：Yoshinari Wakiyama、Ko Kumura、Eijiro Umemura、Satomi Masaki、Kazutaka Ueda、Yasuo Sato、Yoko Hirai、Yoshio Hayashi、Keiichi Ajito

  DOI：10.1038/ja.2017.114

  日期：2018.2

  group at the C-7 position exhibited significantly strong activities against S. pneumoniae and S. pyogenes with an erm gene even when compared with those of telithromycin. Finally, in vivo efficacy of selected two derivatives was evaluated in a rat pulmonary infection model with resistant S. pneumoniae with erm + mef genes. One of them exhibited strong and constant in vivo efficacy in this model, and both

  为了修饰在C-6和C-7位置的林可霉素，我们制备了在钯应用中具有6-氨基取代的胡椒酸和C-7位置的对位苯硫基的目标分子。 -催化的交叉偶联是关键反应。作为在6位上的结构-活性关系（SAR）研究的结果，具有4'-顺式-（环丙基甲基）哌啶的类似物对具有erm基因的肺炎链球菌和化脓性链球菌具有显着强的抗菌活性。在SAR的基础上，我们通过转化C-7取代基进一步合成了具有4'-顺-（环丙基甲基）哌啶的新型类似物。所以，即使与telithromycin相比，在C-7位上具有对-杂芳香族苯硫基的新型衍生物也对具有erm基因的肺炎链球菌和化脓性链球菌具有很强的活性。最后，在具有erm + mef基因抗性肺炎链球菌的大鼠肺部感染模型中评估了选定的两种衍生物的体内功效。在该模型中，它们之一显示出强而恒定的体内功效，并且两种化合物对具有mef基因的抗性肺炎链球菌均显示出强大的体内功效。